BIOCQ — Biocept Share News
0.000.00%
Last trade - 00:00HealthcareHighly SpeculativeMicro Cap
- $0.00m
- -$4.46m
- $25.86m
Brief: Biocept Reports 2020 Fourth Quarter And Full Year Financial Results
Biocept: Rises on supply deal for COVID-19 test kit
Brief: Aegea Biotechnologies Announces Supply Agreement With Biocept For New Covid-19 Test
Brief: Biocept And Protean BioDiagnostics Establish Research Collaboration To Demonstrate Advantages Of Biocept’s Target Selector Assay Kit For Non-Small Cell Lung Cancer Patients
Brief: Biocept Provides Update On COVID-19 Testing With More Than 250,000 Samples Received
Brief: Biocept Enters Into Laboratory Services Agreements With Two Southern California Regional Independent Physician Associations
Brief: Biocept Inc Receives More Than 150,000 Samples For Covid-19 Rt-Pcr Testing To Date
Brief: Biocept's Target Selector Liquid Biopsy Shows High Accuracy In Monitoring Metastatic Breast Cancer
Brief: Study Shows Biocept's Assays Are Viable, Sensitive For Detecting Tumor Cells, Biomarkers In The Cerebrospinal Fluid Of Patients With Breast, Lung Cancer
Biocept Inc: Rises on COVID-19 testing update
Brief: Biocept Provides Update On Covid-19 Testing With More Than 100,000 Samples Received
Brief: Biocept Receives Hong Kong Patent Covering The Enhanced Detection Of Rare Cells, Including Cancer Cells
Brief: Biocept Awarded Broad Japanese Patent
Brief: Biocept Provides Update On Covid-19 Testing With More Than 80,000 Samples Received
Brief: Biocept Appoints Samuel D. Riccitelli To Its Board Of Directors
U.S. STOCKS ON THE MOVE-Facebook, Amazon.com, Nvidia
Biocept: Up on COVID-19 testing, progress with collection kits
Brief: Biocept Provides Update On COVID-19 Testing
U.S. STOCKS ON THE MOVE-TC PipeLines, energy stocks, big banks, Plug Power